母亲年龄相关的先天性心脏病风险是可修改的
Claire E Schulkey1, Suk D Regmi1, Rachel A Magnan1
1Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri 63110 USA.
Nature
|April 2, 2015
概括
母亲年龄增加了先天性心脏病的风险,独立于染色体问题. 这项研究确定了这种风险的母体基础,这种风险可以通过母体炼来减轻.
科学领域:
- 发育生物学是发展生物学.
- 遗传学 是一个遗传学.
- 生殖医学是一种生殖医学.
背景情况:
- 母亲年龄是新生儿先天性心脏病 (CHD) 的已知危险因素,即使没有染色体异常.
- 这种与年龄相关的风险的根本原因,无论是母体还是卵细胞相关的,仍然不清楚.
- 之前的研究已经确定了Nkx2-5基因突变作为研究小鼠对心脏病产妇年龄影响的模型.
研究的目的:
- 研究母亲对与年龄相关的先天性心脏病风险的贡献.
- 探索潜在的机制,包括饮食和遗传学,影响这种风险.
- 确定可以减轻与母亲年龄相关的CHD风险的干预措施.
主要方法:
- 在携带Nkx2-5突变的年轻和老雌性小鼠之间进行相互的卵巢移植.
- 管理高脂肪饮食,以评估它们对母亲衰老的影响.
- 分析母亲的菌株背景,以评估遗传影响.
- 为不同生命阶段的母亲实施自愿运动计划.
主要成果:
- 卵巢移植证实了老鼠与年龄相关的冠心病风险的母体基础.
- 高脂肪饮食并没有加剧母亲衰老的影响,这表明高血糖和肥胖不是主要的驱动因素.
- 风险证明了由母亲的菌株背景影响的定量遗传变异.
- 随意炼,无论开始时间如何,在老年母亲中显著降低了心脏病风险.
结论:
- 这项研究在Nkx2-5小鼠模型中确定了与年龄相关的心脏病风险的母性来源,而不是卵细胞特异性来源.
- 母亲的生活方式干预,特别是运动,可以有效地降低后代的心脏病风险,即使存在遗传倾向.
- 这些发现凸显了以母亲为中心的策略在预防先天性心脏缺陷方面的潜力.
相关概念视频
Meiosis vs. Mitosis
75.2K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
75.2K
Mitral Stenosis I: Introduction
1.6K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.6K
Mitral Valve Prolapse III: Nursing Management
541
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
541
Heart Failure I: Introduction
1.3K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Mitral Regurgitation I: Introduction
1.2K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Teratogenicity
4.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K


